Andrew A. Dahl
President / Chief Executive Officer & Director
Mr. Dahl was formerly a principal consultant and managing director of Great Northern & Reserve Partners, LLC, a marketing strategy and business planning consultancy focused on the biomed and biotech sectors, since 2005. For the previous 20 years, Mr. Dahl served as President of Dawber & Company, Inc., one of the largest independent marketing & consulting firms in the Midwest, with an extensive Fortune 500 client roster that included GM, Ford, Northwest, Xerox, AT&T and Compuware, among others. He attended the College for Creative Studies and Wayne State University. Mr. Dahl holds three US patents for interactive multimedia and is a named inventor in one recent biotech patent and several biomed patent applications.
Chief Financial Officer
Keith Marchiando has 25 years of experience leading finance organizations of manufacturing and technology companies. He possesses a deep functional experience and technical knowledge in all aspects of corporate finance, financial planning, and accounting. He brings broad experience in a number of industries and company sizes and has extensive experience in information technology and human resources as well. Mr. Marchiando joined ZIVO Bioscience, Inc. from New US Nonwovens, LLC, a contract manufacturer of personal care and home care products, where he was Chief Financial Officer. At US Nonwovens, he was responsible for all aspects of the company’s financial activities, including strengthening corporate controls, implementing financial planning and developing the Company’s IT strategy. Prior to Nonwovens, he had similar responsibilities in finance-related roles at multiple private and public companies. Mr. Marchiando earned a master’s degree in Business Administration (MBA) in corporate finance from Carnegie Mellon University’s Tepper School of Management and an undergraduate degree in finance and economics at Lehigh University. Mr. Marchiando is a member of Financial Executives International and enjoys photography and cooking in his spare time.
Vice-President, Operations and Product Development
Mr. Fowler served as Vice President of Operations for CPA Global heading their Intellectual Property services division supporting corporations and law firms with their technical challenges and strategic decisions. His academic background includes a B.S. in Chemistry from the University of Mary Washington and a Master’s in Biochemistry from the University of Maryland. Casey has spent a lot of his career in the pharmaceutical industry serving as an intellectual property consultant and authored pieces on the US market forces and the economics of pharmaceuticals.
William P. Pfund
Vice-President, Research & Development
Mr. Pfund brings more than 30 years of technical and operational leadership experience in FDA-regulated companies to his role as Vice-President, Research & Development at ZIVO Bioscience, Inc., including more than 18 years at Pfizer (legacy Upjohn) where he held numerous positions spanning the entire drug discovery and development continuum. He brings a wealth of technical expertise, process control and managerial experience to the Company that will help drive value. Following his tenure at Pfizer, Mr. Pfund served as the Vice President, Product Development for RealBio Technology, Inc., an emerging research tools company, and held Director-level positions at several leading contract research organizations including Eurofins, Covance and NAMSA. Mr. Pfund earned a B.S. (Biology) from the State University of New York, College at Oswego, and a M.S. (Microbiology) from The Ohio State University.
Dr. Amy Steffek
Director, Research & Development
Amy Elizabeth Steffek, Ph.D., serves as the Company’s Director of Research & Development. She earned a Ph.D. in Neuroscience from the University of Michigan in 2007 and completed fellowships in Translational Medicine and Neuroendocrinology at the University of Michigan in 2010. Dr. Steffek has over 13 years of scientific research experience spanning neurology, cardiology, oncology, psychiatry, and endocrinology. As a consultant, she has helped companies develop pharmaceutical products, medical devices, medical IT products, and pre-clinical research services.
Dr. Harlan L. Miller III
Vice-President, Technology and Global Supply
Dr. Miller has nearly 15 years experience in cleantech, agtech, and biotech industries and continues to be dedicated to developing environmentally responsible technologies and sustainable products. As Vice President of Technology and Global Supply at Zivo Bioscience Inc, he is responsible for ZIVO’s algae SuperFarm engineering and for managing a global supply chain to grow ZIVO’s proprietary algal strain and produce quality product. Before joining ZIVO, he was Director of Manufacturing at Global Thermostat, LLC, and managed an engineering project to deliver a first-of-its-kind CO2 direct air capture plant. Prior, he was Senior Director of Technology at Algenol Biotech LLC, where he headed project management, technical development of advanced photobioreactor systems, product development of color additives and proteins derived from algae, and commercial facility engineering. In academia, Dr. Miller studied algae production and the functional role of aquatic plants in marine and aquatic ecosystems. He received his Ph.D. in Marine Sciences from the University of Texas (Austin) Marine Science Institute, after which he served as a Postdoctoral Researcher at the University of Georgia. He also holds a M.S. in Plant Sciences from University of Massachusetts, Amherst and a B.A. in Biology from Trinity College.